New mutations in acetylcholine receptor subunit genes reveal heterogeneity in the slow-channel congenital myasthenic syndrome

Andrew G. Engel, Kinji Ohno, Margherita Milone, Hai Long Wang, Satoshi Nakano, Cecilia Bouzat, J. Ned Pruitt, David O. Hutchinson, Joan M. Brengman, Nina Bren, Joern P. Sieb, Steven M. Sine

Research output: Contribution to journalArticle

169 Citations (Scopus)

Abstract

Mutations in genes encoding the ε, δ, β and α subunits of the end plate acetylcholine (ACh) receptor (AChR) are described and functionally characterized in three slow-channel congenital myasthenic syndrome patients. All three had prolonged end plate currents and AChR channel opening episodes and an end plate myopathy with loss of AChR from degenerating junctional folds. Genetic analysis revealed heterozygous mutations: εL269F and δQ267E in Patient 1, βV266M in Patient 2, and αN217K in Patient 3 that were not detected in 100 normal controls. Patients 1 and 2 have no similarly affected relatives; in Patient 3, the mutation cosegregates with the disease in three generations, εL269F, δQ267E and βV266M occur in the second and αN217K in the first transmembrane domain of AChR subunits; all have been postulated to contribute to the lining of the upper half of the channel lumen and all but δQ267E are positioned toward the channel lumen, and introduce an enlarged side chain. Expression studies in HEK cells indicate that all of the mutations express normal amounts of AChR, εL269F, βV266M, and αN217K slow the rate of channel closure in the presence of ACh and increase apparent affinity for ACh; εL269F and αN217K enhance desensitization, and εL269F and βV266M cause pathologic channel openings in the absence of ACh, rendering the channel leaky, δQ267E has none of these effects and is therefore a rare polymorphism or a benign mutation. The end plate myopathy stems from cationic overloading of the postsynaptic region. The safety margin of neuromuscular transmission is compromised by AChR loss from the junctional folds and by a depolarization block owing to temporal summation of prolonged end plate potentials at physiologic rates of stimulation.

Original languageEnglish (US)
Pages (from-to)1217-1227
Number of pages11
JournalHuman Molecular Genetics
Volume5
Issue number9
DOIs
StatePublished - Sep 1 1996

Fingerprint

Congenital Myasthenic Syndromes
Cholinergic Receptors
Mutation
Genes
Acetylcholine
Muscular Diseases
Excitatory Postsynaptic Potentials
Safety

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Genetics(clinical)

Cite this

New mutations in acetylcholine receptor subunit genes reveal heterogeneity in the slow-channel congenital myasthenic syndrome. / Engel, Andrew G.; Ohno, Kinji; Milone, Margherita; Wang, Hai Long; Nakano, Satoshi; Bouzat, Cecilia; Pruitt, J. Ned; Hutchinson, David O.; Brengman, Joan M.; Bren, Nina; Sieb, Joern P.; Sine, Steven M.

In: Human Molecular Genetics, Vol. 5, No. 9, 01.09.1996, p. 1217-1227.

Research output: Contribution to journalArticle

Engel, AG, Ohno, K, Milone, M, Wang, HL, Nakano, S, Bouzat, C, Pruitt, JN, Hutchinson, DO, Brengman, JM, Bren, N, Sieb, JP & Sine, SM 1996, 'New mutations in acetylcholine receptor subunit genes reveal heterogeneity in the slow-channel congenital myasthenic syndrome', Human Molecular Genetics, vol. 5, no. 9, pp. 1217-1227. https://doi.org/10.1093/hmg/5.9.1217
Engel, Andrew G. ; Ohno, Kinji ; Milone, Margherita ; Wang, Hai Long ; Nakano, Satoshi ; Bouzat, Cecilia ; Pruitt, J. Ned ; Hutchinson, David O. ; Brengman, Joan M. ; Bren, Nina ; Sieb, Joern P. ; Sine, Steven M. / New mutations in acetylcholine receptor subunit genes reveal heterogeneity in the slow-channel congenital myasthenic syndrome. In: Human Molecular Genetics. 1996 ; Vol. 5, No. 9. pp. 1217-1227.
@article{b87994d94304466d9011d9b5730de61c,
title = "New mutations in acetylcholine receptor subunit genes reveal heterogeneity in the slow-channel congenital myasthenic syndrome",
abstract = "Mutations in genes encoding the ε, δ, β and α subunits of the end plate acetylcholine (ACh) receptor (AChR) are described and functionally characterized in three slow-channel congenital myasthenic syndrome patients. All three had prolonged end plate currents and AChR channel opening episodes and an end plate myopathy with loss of AChR from degenerating junctional folds. Genetic analysis revealed heterozygous mutations: εL269F and δQ267E in Patient 1, βV266M in Patient 2, and αN217K in Patient 3 that were not detected in 100 normal controls. Patients 1 and 2 have no similarly affected relatives; in Patient 3, the mutation cosegregates with the disease in three generations, εL269F, δQ267E and βV266M occur in the second and αN217K in the first transmembrane domain of AChR subunits; all have been postulated to contribute to the lining of the upper half of the channel lumen and all but δQ267E are positioned toward the channel lumen, and introduce an enlarged side chain. Expression studies in HEK cells indicate that all of the mutations express normal amounts of AChR, εL269F, βV266M, and αN217K slow the rate of channel closure in the presence of ACh and increase apparent affinity for ACh; εL269F and αN217K enhance desensitization, and εL269F and βV266M cause pathologic channel openings in the absence of ACh, rendering the channel leaky, δQ267E has none of these effects and is therefore a rare polymorphism or a benign mutation. The end plate myopathy stems from cationic overloading of the postsynaptic region. The safety margin of neuromuscular transmission is compromised by AChR loss from the junctional folds and by a depolarization block owing to temporal summation of prolonged end plate potentials at physiologic rates of stimulation.",
author = "Engel, {Andrew G.} and Kinji Ohno and Margherita Milone and Wang, {Hai Long} and Satoshi Nakano and Cecilia Bouzat and Pruitt, {J. Ned} and Hutchinson, {David O.} and Brengman, {Joan M.} and Nina Bren and Sieb, {Joern P.} and Sine, {Steven M.}",
year = "1996",
month = "9",
day = "1",
doi = "10.1093/hmg/5.9.1217",
language = "English (US)",
volume = "5",
pages = "1217--1227",
journal = "Human Molecular Genetics",
issn = "0964-6906",
publisher = "Oxford University Press",
number = "9",

}

TY - JOUR

T1 - New mutations in acetylcholine receptor subunit genes reveal heterogeneity in the slow-channel congenital myasthenic syndrome

AU - Engel, Andrew G.

AU - Ohno, Kinji

AU - Milone, Margherita

AU - Wang, Hai Long

AU - Nakano, Satoshi

AU - Bouzat, Cecilia

AU - Pruitt, J. Ned

AU - Hutchinson, David O.

AU - Brengman, Joan M.

AU - Bren, Nina

AU - Sieb, Joern P.

AU - Sine, Steven M.

PY - 1996/9/1

Y1 - 1996/9/1

N2 - Mutations in genes encoding the ε, δ, β and α subunits of the end plate acetylcholine (ACh) receptor (AChR) are described and functionally characterized in three slow-channel congenital myasthenic syndrome patients. All three had prolonged end plate currents and AChR channel opening episodes and an end plate myopathy with loss of AChR from degenerating junctional folds. Genetic analysis revealed heterozygous mutations: εL269F and δQ267E in Patient 1, βV266M in Patient 2, and αN217K in Patient 3 that were not detected in 100 normal controls. Patients 1 and 2 have no similarly affected relatives; in Patient 3, the mutation cosegregates with the disease in three generations, εL269F, δQ267E and βV266M occur in the second and αN217K in the first transmembrane domain of AChR subunits; all have been postulated to contribute to the lining of the upper half of the channel lumen and all but δQ267E are positioned toward the channel lumen, and introduce an enlarged side chain. Expression studies in HEK cells indicate that all of the mutations express normal amounts of AChR, εL269F, βV266M, and αN217K slow the rate of channel closure in the presence of ACh and increase apparent affinity for ACh; εL269F and αN217K enhance desensitization, and εL269F and βV266M cause pathologic channel openings in the absence of ACh, rendering the channel leaky, δQ267E has none of these effects and is therefore a rare polymorphism or a benign mutation. The end plate myopathy stems from cationic overloading of the postsynaptic region. The safety margin of neuromuscular transmission is compromised by AChR loss from the junctional folds and by a depolarization block owing to temporal summation of prolonged end plate potentials at physiologic rates of stimulation.

AB - Mutations in genes encoding the ε, δ, β and α subunits of the end plate acetylcholine (ACh) receptor (AChR) are described and functionally characterized in three slow-channel congenital myasthenic syndrome patients. All three had prolonged end plate currents and AChR channel opening episodes and an end plate myopathy with loss of AChR from degenerating junctional folds. Genetic analysis revealed heterozygous mutations: εL269F and δQ267E in Patient 1, βV266M in Patient 2, and αN217K in Patient 3 that were not detected in 100 normal controls. Patients 1 and 2 have no similarly affected relatives; in Patient 3, the mutation cosegregates with the disease in three generations, εL269F, δQ267E and βV266M occur in the second and αN217K in the first transmembrane domain of AChR subunits; all have been postulated to contribute to the lining of the upper half of the channel lumen and all but δQ267E are positioned toward the channel lumen, and introduce an enlarged side chain. Expression studies in HEK cells indicate that all of the mutations express normal amounts of AChR, εL269F, βV266M, and αN217K slow the rate of channel closure in the presence of ACh and increase apparent affinity for ACh; εL269F and αN217K enhance desensitization, and εL269F and βV266M cause pathologic channel openings in the absence of ACh, rendering the channel leaky, δQ267E has none of these effects and is therefore a rare polymorphism or a benign mutation. The end plate myopathy stems from cationic overloading of the postsynaptic region. The safety margin of neuromuscular transmission is compromised by AChR loss from the junctional folds and by a depolarization block owing to temporal summation of prolonged end plate potentials at physiologic rates of stimulation.

UR - http://www.scopus.com/inward/record.url?scp=10144229353&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=10144229353&partnerID=8YFLogxK

U2 - 10.1093/hmg/5.9.1217

DO - 10.1093/hmg/5.9.1217

M3 - Article

C2 - 8872460

AN - SCOPUS:10144229353

VL - 5

SP - 1217

EP - 1227

JO - Human Molecular Genetics

JF - Human Molecular Genetics

SN - 0964-6906

IS - 9

ER -